{{Rsnum
|rsid=6707272
|Chromosome=2
|position=229744433
|Orientation=plus
|GMAF=0.2943
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 56.6 | 36.3 | 7.1
| HCB | 69.3 | 28.5 | 2.2
| JPT | 60.2 | 31.0 | 8.8
| YRI | 40.1 | 49.7 | 10.2
| ASW | 42.9 | 48.2 | 8.9
| CHB | 69.3 | 28.5 | 2.2
| CHD | 59.6 | 33.9 | 6.4
| GIH | 48.5 | 45.5 | 5.9
| LWK | 36.4 | 43.6 | 20.0
| MEX | 56.9 | 37.9 | 5.2
| MKK | 24.4 | 60.3 | 15.4
| TSI | 35.3 | 52.0 | 12.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=23423446
|Title=A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}